Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Buprenorphine
1.2.3 Methadone
1.2.4 Naltrexone
1.3 Market by Application
1.3.1 Global Opioid Use Disorder Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Moderate Pain Treatment
1.3.3 Severe Pain Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Use Disorder Market Perspective (2018-2033)
2.2 Opioid Use Disorder Growth Trends by Region
2.2.1 Global Opioid Use Disorder Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Opioid Use Disorder Historic Market Size by Region (2018-2023)
2.2.3 Opioid Use Disorder Forecasted Market Size by Region (2024-2033)
2.3 Opioid Use Disorder Market Dynamics
2.3.1 Opioid Use Disorder Industry Trends
2.3.2 Opioid Use Disorder Market Drivers
2.3.3 Opioid Use Disorder Market Challenges
2.3.4 Opioid Use Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Use Disorder Players by Revenue
3.1.1 Global Top Opioid Use Disorder Players by Revenue (2018-2023)
3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2018-2023)
3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Use Disorder Revenue
3.4 Global Opioid Use Disorder Market Concentration Ratio
3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2022
3.5 Opioid Use Disorder Key Players Head office and Area Served
3.6 Key Players Opioid Use Disorder Product Solution and Service
3.7 Date of Enter into Opioid Use Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Use Disorder Breakdown Data by Type
4.1 Global Opioid Use Disorder Historic Market Size by Type (2018-2023)
4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2024-2033)
5 Opioid Use Disorder Breakdown Data by Application
5.1 Global Opioid Use Disorder Historic Market Size by Application (2018-2023)
5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Opioid Use Disorder Market Size (2018-2033)
6.2 North America Opioid Use Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Opioid Use Disorder Market Size by Country (2018-2023)
6.4 North America Opioid Use Disorder Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Use Disorder Market Size (2018-2033)
7.2 Europe Opioid Use Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Opioid Use Disorder Market Size by Country (2018-2023)
7.4 Europe Opioid Use Disorder Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Use Disorder Market Size (2018-2033)
8.2 Asia-Pacific Opioid Use Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Opioid Use Disorder Market Size by Region (2018-2023)
8.4 Asia-Pacific Opioid Use Disorder Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioid Use Disorder Market Size (2018-2033)
9.2 Latin America Opioid Use Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Opioid Use Disorder Market Size by Country (2018-2023)
9.4 Latin America Opioid Use Disorder Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Use Disorder Market Size (2018-2033)
10.2 Middle East & Africa Opioid Use Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Opioid Use Disorder Market Size by Country (2018-2023)
10.4 Middle East & Africa Opioid Use Disorder Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Detail
11.1.2 Indivior Business Overview
11.1.3 Indivior Opioid Use Disorder Introduction
11.1.4 Indivior Revenue in Opioid Use Disorder Business (2018-2023)
11.1.5 Indivior Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Detail
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Opioid Use Disorder Introduction
11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2018-2023)
11.2.5 Alkermes Recent Development
11.3 Titan Pharmaceuticals
11.3.1 Titan Pharmaceuticals Company Detail
11.3.2 Titan Pharmaceuticals Business Overview
11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2018-2023)
11.3.5 Titan Pharmaceuticals Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Detail
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2018-2023)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 MediciNova
11.6.1 MediciNova Company Detail
11.6.2 MediciNova Business Overview
11.6.3 MediciNova Opioid Use Disorder Introduction
11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2018-2023)
11.6.5 MediciNova Recent Development
11.7 Orexo
11.7.1 Orexo Company Detail
11.7.2 Orexo Business Overview
11.7.3 Orexo Opioid Use Disorder Introduction
11.7.4 Orexo Revenue in Opioid Use Disorder Business (2018-2023)
11.7.5 Orexo Recent Development
11.8 Camurus
11.8.1 Camurus Company Detail
11.8.2 Camurus Business Overview
11.8.3 Camurus Opioid Use Disorder Introduction
11.8.4 Camurus Revenue in Opioid Use Disorder Business (2018-2023)
11.8.5 Camurus Recent Development
11.9 Omeros
11.9.1 Omeros Company Detail
11.9.2 Omeros Business Overview
11.9.3 Omeros Opioid Use Disorder Introduction
11.9.4 Omeros Revenue in Opioid Use Disorder Business (2018-2023)
11.9.5 Omeros Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Buprenorphine
Table 3. Key Players of Methadone
Table 4. Key Players of Naltrexone
Table 5. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Opioid Use Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Opioid Use Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Opioid Use Disorder Market Share by Region (2018-2023)
Table 9. Global Opioid Use Disorder Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Opioid Use Disorder Market Share by Region (2024-2033)
Table 11. Opioid Use Disorder Market Trends
Table 12. Opioid Use Disorder Market Drivers
Table 13. Opioid Use Disorder Market Challenges
Table 14. Opioid Use Disorder Market Restraints
Table 15. Global Opioid Use Disorder Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Opioid Use Disorder Market Share by Players (2018-2023)
Table 17. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2022)
Table 18. Ranking of Global Top Opioid Use Disorder Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Opioid Use Disorder Product Solution and Service
Table 22. Date of Enter into Opioid Use Disorder Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Opioid Use Disorder Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2018-2023)
Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2024-2033)
Table 28. Global Opioid Use Disorder Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Opioid Use Disorder Revenue Market Share by Application (2018-2023)
Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Opioid Use Disorder Revenue Market Share by Application (2024-2033)
Table 32. North America Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Opioid Use Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Opioid Use Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Opioid Use Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Opioid Use Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Opioid Use Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Opioid Use Disorder Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Opioid Use Disorder Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Opioid Use Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Opioid Use Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Opioid Use Disorder Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Opioid Use Disorder Market Size by Country (2024-2033) & (US$ Million)
Table 47. Indivior Company Detail
Table 48. Indivior Business Overview
Table 49. Indivior Opioid Use Disorder Product
Table 50. Indivior Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 51. Indivior Recent Development
Table 52. Alkermes Company Detail
Table 53. Alkermes Business Overview
Table 54. Alkermes Opioid Use Disorder Product
Table 55. Alkermes Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 56. Alkermes Recent Development
Table 57. Titan Pharmaceuticals Company Detail
Table 58. Titan Pharmaceuticals Business Overview
Table 59. Titan Pharmaceuticals Opioid Use Disorder Product
Table 60. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 61. Titan Pharmaceuticals Recent Development
Table 62. Hikma Pharmaceuticals Company Detail
Table 63. Hikma Pharmaceuticals Business Overview
Table 64. Hikma Pharmaceuticals Opioid Use Disorder Product
Table 65. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 66. Hikma Pharmaceuticals Recent Development
Table 67. Teva Pharmaceuticals Company Detail
Table 68. Teva Pharmaceuticals Business Overview
Table 69. Teva Pharmaceuticals Opioid Use Disorder Product
Table 70. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 71. Teva Pharmaceuticals Recent Development
Table 72. MediciNova Company Detail
Table 73. MediciNova Business Overview
Table 74. MediciNova Opioid Use Disorder Product
Table 75. MediciNova Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 76. MediciNova Recent Development
Table 77. Orexo Company Detail
Table 78. Orexo Business Overview
Table 79. Orexo Opioid Use Disorder Product
Table 80. Orexo Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 81. Orexo Recent Development
Table 82. Camurus Company Detail
Table 83. Camurus Business Overview
Table 84. Camurus Opioid Use Disorder Product
Table 85. Camurus Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 86. Camurus Recent Development
Table 87. Omeros Company Detail
Table 88. Omeros Business Overview
Table 89. Omeros Opioid Use Disorder Product
Table 90. Omeros Revenue in Opioid Use Disorder Business (2018-2023) & (US$ Million)
Table 91. Omeros Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Use Disorder Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Opioid Use Disorder Market Share by Type: 2022 VS 2033
Figure 3. Buprenorphine Features
Figure 4. Methadone Features
Figure 5. Naltrexone Features
Figure 6. Global Opioid Use Disorder Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Opioid Use Disorder Market Share by Application: 2022 VS 2033
Figure 8. Moderate Pain Treatment Case Studies
Figure 9. Severe Pain Treatment Case Studies
Figure 10. Opioid Use Disorder Report Years Considered
Figure 11. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Opioid Use Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Opioid Use Disorder Market Share by Region: 2022 VS 2033
Figure 14. Global Opioid Use Disorder Market Share by Players in 2022
Figure 15. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2022
Figure 17. North America Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Opioid Use Disorder Market Share by Country (2018-2033)
Figure 19. United States Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Opioid Use Disorder Market Share by Country (2018-2033)
Figure 23. Germany Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Opioid Use Disorder Market Share by Region (2018-2033)
Figure 31. China Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Opioid Use Disorder Market Share by Country (2018-2033)
Figure 39. Mexico Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Opioid Use Disorder Market Share by Country (2018-2033)
Figure 43. Turkey Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 46. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 47. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 48. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 50. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 51. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 52. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 53. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed